Volume 8, Issue 4 (11-2023)
J Res Dent Maxillofac Sci 2023, 8(4): 274-279 |
Back to browse issues page
Ethics code: Not applicable
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mirzaee S, Shoorgashti R, Sadri D, Farhadi S. Comparison of EGFR Expression in Ameloblastoma and Odontogenic Keratocyst. J Res Dent Maxillofac Sci 2023; 8 (4) :274-279
URL: http://jrdms.dentaliau.ac.ir/article-1-502-en.html
URL: http://jrdms.dentaliau.ac.ir/article-1-502-en.html
1- Private Dentistry Practice, Tehran, Iran
2- Oral and Maxillofacial Pathology Department, Faculty of Dentistry, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
3- Oral and Maxillofacial Pathology Department, Faculty of Dentistry, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran , dr.sfarhadi@gmail.com
2- Oral and Maxillofacial Pathology Department, Faculty of Dentistry, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
3- Oral and Maxillofacial Pathology Department, Faculty of Dentistry, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran , dr.sfarhadi@gmail.com
Abstract: (501 Views)
| Background and Aim: Ameloblastoma (AM) and odontogenic keratocyst (OKC) are common lesions with a high recurrence rate. Epidermal growth factor receptor (EGFR) regulates cell proliferation and survival. Considering the controversial results of previous studies regarding the expression of EGFR in odontogenic cysts, this study aimed to compare the expression of EGFR in AM and OKC. Materials and Methods: In this descriptive study, 49 specimens (20 AM and 26 OKC) were evaluated. Five micrometer sections were made for immunohistochemical staining. Immunohistochemical analysis was performed using super-sensitive one-step polymer-HRP. Expression of EGFR was first assessed quantitatively by measuring the count of membrane- and/or cytoplasm-stained epithelial cells in AM (ameloblastoma-like cells, stellate reticulum, and all epithelial cell layers) and OKC (basal layer, suprabasal and basal layers, and all epithelial cell layers). Next, each specimen's mean percentage of stained cells was scored and classified into four groups (less than 5%, 5-25%, 25-50%, and more than 50% stained cells). Data were analyzed by t-test and Mann-Whitney test to compare the mean EGFR expression and the percentage of stained cells. The Chi-square test was used to compare the location of EGFR expression. Results: The mean percentage of EGFR expression was 81.39±10.41% in AM and 78.05±19.27% in OKC. The results showed no significant difference between AM and OKC regarding EGFR expression, EGFR score (P=0.141), or EGFR expression in different layers (P=0.303). |
Conclusion: EGFR expression showed no significant difference between AM and OKC.
Type of Study: Original article |
Subject:
Oral pathology
References
1. Henriques ÁC, Vasconcelos MG, Galvão HC, de Souza LB, de Almeida Freitas R. Comparative analysis of the immunohisto-chemical expression of collagen IV, MMP-9, and TIMP-2 in odon-togenic cysts and tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Oct;112(4):468-75. [DOI:10.1016/j.tripleo.2011.05.033] [PMID]
2. Neville BW, Damm DD, Allen CM, Bouquot JE. Oral and Maxillo-facial Pathology. 3th ed. Philadelphia: Saunders; 2008. 984 p.
3. Arkhipov A, Shan Y, Das R, Endres NF, Eastwood MP, Wem-mer DE, Kuriyan J, Shaw DE. Architecture and membrane interactions of the EGF receptor. Cell. 2013 Jan 31;152(3):557-69. [DOI:10.1016/j.cell.2012.12.030] [PMID] []
4. Briki S, Elleuch W, Karray F, Abdelmoula M, Tanoubi I. Cysts and tumors of the jaws treated by marsupialization: A descrip-tion of 4 clinical cases. J Clin Exp Dent. 2019;11 (6):e565-9. [DOI:10.4317/jced.55563] [PMID] []
5. Shoorgashti R, Sadri D, Farhadi S. Expression of Epidermal Growth Factor Receptor by Odontogenic Cysts: A comparative Study of Dentigerous Cyst and Odontogenic Kera-tocyst.J Res Dent Sci. 2020;17(2):127-36. [DOI:10.29252/jrds.17.2.127]
6. Al-Moraissi EA, Kaur A, Gomez RS, Ellis E 3rd. Effectiveness of different treatments for odontogenic keratocyst: a network meta-analysis. Int J Oral Maxillofac Surg. 2023 Jan;52(1):32-43. [DOI:10.1016/j.ijom.2022.09.004] [PMID]
7. Ceresa BP, Peterson JL. Cell and molecular biology of epidermal growth factor receptor. Int Rev Cell Mol Biol. 2014;313:145-78. [DOI:10.1016/B978-0-12-800177-6.00005-0] [PMID]
8. de Oliveira MG, Lauxen Ida S, Chaves AC, Rados PV, Sant'Ana Filho M. Odontogenic epithelium: immunolabeling of Ki-67, EGFR and survivin in pericoronal follicles, dentigerous cysts and keratocystic odontogenic tumors. Head Neck Pathol. 2011 Mar;5(1):1-7. [DOI:10.1007/s12105-010-0216-0] [PMID] []
9. Sabbah DA, Hajjo R, Sweidan K. Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors. Curr Top Med Chem. 2020;20(10):815-34. [DOI:10.2174/1568026620666200303123102] [PMID]
10. Iradyan M, Iradyan N, Hulin P, Hambardzumyan A, Gyulkhandanyan A, Alves de Sousa R, Hessani A, Roussakis C, Bollot G, Bauvais C, Sakanyan V. Targeting Degradation of EGFR through the Allosteric Site Leads to Cancer Cell Detachment-Promoted Death. Cancers (Basel). 2019 Aug 1; 11(8):1094. [DOI:10.3390/cancers11081094] [PMID] []
11. He J, Huang Z, Han L, Gong Y, Xie C. Mechanisms and manage-ment of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review). Int J Oncol. 2021 Nov;59(5):90. [DOI:10.3892/ijo.2021.5270] [PMID] []
12. Harrison PT, Vyse S, Huang PH. Rare epidermal growth fac-tor receptor (EGFR) mutations in non-small cell lung cancer. Semin Cancer Biol. 2020 Apr;61:167-79. [DOI:10.1016/j.semcancer.2019.09.015] [PMID] []
13. Ayati A, Moghimi S, Salarinejad S, Safavi M, Pouramiri B, Foroumadi A. A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy. Bioorg Chem. 2020 Jun;99:103811. [DOI:10.1016/j.bioorg.2020.103811] [PMID]
14. Speight PM, Takata T. New tumour entities in the 4th edition of the World Health Organization Classification of Head and Neck tumours: odontogenic and maxillofacial bone tumours. Virchows Arch. 2018 Mar;472(3):331-9. [DOI:10.1007/s00428-017-2182-3] [PMID] []
15. Li TJ, Browne RM, Matthews JB. Expression of epidermal growth factor receptors by odontogenic jaw cysts. Virchows Arch A Pathol Anat Histopathol. 1993;423(2):137-44. [DOI:10.1007/BF01606588] [PMID]
16. de Vicente JC, Torre-Iturraspe A, Gutiérrez AM, Lequerica-Fernández P. Immunohistochemical comparative study of the odontogenic keratocysts and other odontogenic lesions. Med Oral Patol Oral Cir Bucal. 2010 Sep 1;15(5):e 709-15. [DOI:10.4317/medoral.15.e709] [PMID]
17. Razavi SM, Torabinia N, Mohajeri MR, Shahriyary S, Ghalego-lab S, Nouri S. Expression of Bcl-2 and epithelial growth factor receptor proteins in keratocystic odontogenic tumor in com-parison with dentigerous cyst and ameloblastoma. Dent Res J (Isfahan). 2015 Jul-Aug; 12(4): 342-7. [DOI:10.4103/1735-3327.161451] [PMID] []
18. Siwach P, Joy T, Tupkari J, Thakur A. Controversies in Odon-togenic Tumours: Review. Sultan Qaboos Univ Med J. 2017 Aug;17(3):e268-76. [DOI:10.18295/squmj.2017.17.03.003] [PMID] []
19. Mosqueda-Taylor A. New findings and controversies in odontogenic tumors. Med Oral Patol Oral Cir Bucal. 2008 Sep 1;13(9):E555-8.
20. El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. WHO Classification of Head and Neck Tumours. 4th ed. Lyon: IARC Press; 2017..
21. Rajendra Santosh AB. Odontogenic Cysts. Dent Clin North Am. 2020 Jan;64(1):105-19. [DOI:10.1016/j.cden.2019.08.002] [PMID]
22. Maruthanila VL, Elancheran R, Kunnumakkara AB, Kabilan S, Kotoky J. Recent development of targeted approaches for the treatment of breast cancer. Breast Cancer. 2017 Mar;24(2):191-219. [DOI:10.1007/s12282-016-0732-1] [PMID]
23. Alaeddini M, Salah S, Dehghan F, Eshghyar N, Etemad-Moghadam S. Comparison of angiogenesis in keratocystic odontogenic tumours, dentigerous cysts and ame-loblastomas. Oral Dis. 2009 Sep;15(6):422-7. [DOI:10.1111/j.1601-0825.2009.01566.x] [PMID]
24. Kaufman NEM, Dhingra S, Jois SD, Vicente MDGH. Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR). Molecules. 2021 Feb 18;26(4):1076. [DOI:10.3390/molecules26041076] [PMID] []
25. Schreier B, Dubourg V, Hübschmann S, Rabe S, Mildenberger S, Gekle M. Synergy of epidermal growth factor (EGFR) and angiotensin II (AT1R) receptor determines composition and temporal pattern of transcriptome variation. Cell Mol Life Sci. 2021 Dec 18;79(1):57. [DOI:10.1007/s00018-021-04065-5] [PMID] []
26. Wu L, Cheng Y, Geng D, Fan Z, Lin B, Zhu Q, Li J, Qin W, Yi W. O-GlcNAcylation regulates epidermal growth factor receptor intracellular trafficking and signaling. Proc Natl Acad Sci U S A. 2022 Mar 8;119(10):e2107453119. [DOI:10.1073/pnas.2107453119] [PMID] []
27. Arce K, Streff CS, Ettinger KS. Pediatric Odontogenic Cysts of the Jaws. Oral Maxillofac Surg Clin North Am. 2016 Feb;28(1):21-30. [DOI:10.1016/j.coms.2015.07.003] [PMID]
28. de Oliveira MG, Lauxen Ida S, Chaves AC, Rados PV, Sant'Ana Filho M. Odontogenic epithelium: immunolabeling of Ki-67, EGFR and survivin in pericoronal follicles, dentigerous cysts and keratocystic odontogenic tumors. Head Neck Pathol. 2011 Mar;5(1):1-7. [DOI:10.1007/s12105-010-0216-0] [PMID] []
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
